Big Pharma versus Healthy Women: Yaz Side Effects
Drospirenone is just one of the causes attributed to the barrage of Yaz side effects reported regularly in America. Drospirenone is an ingredient allegedly unlike other progestins in the United States and was not found in America before it made an appearance in Yasmin, Yaz and Ocella. Also consider that the FDA released warning letter to the makers of Ocella, Yasmin and Yaz for using low-quality batches of drospirenone from Germany and you have the makings of a cautionary tale involving Big Pharma and its neglect for the people taking its pharmaceuticals.
Among the different contestations impending on Yasmin, Yaz and Ocella birth control, the pills also include drospirenone, an ingredient not in other oral contraceptives. The British Medical Journal released studies in August 2009 showing an increased risk of venous blood clots in women taking drospirenone as opposed to those who took other oral contraceptives. In that same month, the FDA issued an unrelated advisory to Bayer Pharmaceuticals, makers of Yaz, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and well-being, these articles have been made available free online.
Women taking Yasmin, Yaz or Ocella to avoid becoming pregnant or to treat PMDD (Premenstrual Dysphoric Disorder) or severe acne have reportedly withstood major injury to their health and wellness. Although not all pharmaceuticals are one-hundred percent safe, the main issue surrounding Yaz seems to be that the original commercials downplayed the health risks and side effects. This attracted users to the product that may not have taken it otherwise had they been properly informed about the risks posed by Ocella, Yasmin and Yaz.